---
input_text: Abnormal visual scanning and impaired mental state recognition in pre-manifest
  Huntington disease. Huntington's disease (HD) is a genetic neurodegenerative disorder
  that affects not only the motor but also the cognitive and the neuropsychiatric
  domain. In particular, deficits in mental state recognition may emerge already at
  early pre-manifest stages of the disease. The aim of this research was to explore
  the relation between visual scanning behavior and complex mental state recognition
  in individuals with pre-manifest HD (preHD). Eighteen preHD and eighteen age- and
  gender-matched healthy controls took the revised "Reading the Mind in the Eyes"
  test while their eye-movements were tracked. In addition to the expected deficits
  in mental state recognition, preHD showed abnormalities concerning all three scanning
  variables we considered, namely the absolute number of fixations (FC), the average
  fixation duration (AFD), and the percentage of time spent fixating (FTR). In preHD,
  FC and FTR but not AFD predicted mental state recognition over and beyond general
  disease-related declines in cognition and motor functioning. Notably, preHD showed
  abnormal vertical and horizontal fixation patterns, and these patterns predicted
  mental state recognition, suggesting the involvement of mechanisms related to the
  embodied processing of emotional stimuli. Overall, our results suggest that impaired
  facial mental state recognition in pre-manifest HD is partly due to emotional-motivational
  factors affecting the visual scanning of facial expressions.
raw_completion_output: |-
  primary_disease: Huntington's disease

  medical_actions: Eye-movement tracking; revised "Reading the Mind in the Eyes" test

  symptoms: Abnormal visual scanning; impaired mental state recognition; deficits in mental state recognition; abnormalities in fixation variables (absolute number of fixations, average fixation duration, percentage of time spent fixating); abnormal vertical and horizontal fixation patterns

  chemicals: 

  action_annotation_relationships: Eye-movement tracking TREATS abnormal visual scanning IN Huntington's disease; revised "Reading the Mind in the Eyes" test TREATS impaired mental state recognition IN Huntington's disease
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  revised "Reading the Mind in the Eyes" test TREATS impaired mental state recognition IN Huntington's disease

  ===

extracted_object:
  primary_disease: MONDO:0007739
  medical_actions:
    - Eye-movement tracking
    - revised "Reading the Mind in the Eyes" test
  symptoms:
    - Abnormal visual scanning
    - impaired mental state recognition
    - deficits in mental state recognition
    - abnormalities in fixation variables (absolute number of fixations, average fixation
      duration, percentage of time spent fixating)
    - abnormal vertical and horizontal fixation patterns
  action_annotation_relationships:
    - subject: <Eye-movement tracking>
      predicate: <TREATS>
      object: <abnormal visual scanning>
      qualifier: <Huntington's disease>
      subject_qualifier: <None>
      object_qualifier: <None>
      subject_extension: <None>
      object_extension: <None>
    - subject: <"Reading the Mind in the Eyes" test>
      predicate: <TREATS>
      object: <impaired mental state recognition>
      qualifier: <Huntington's disease>
      subject_qualifier: <revised>
      object_qualifier: <NA>
      subject_extension: <NA>
      object_extension: <NA>
named_entities:
  - id: MONDO:0007739
    label: Huntington Disease
  - id: CHEBI:16908
    label: NADH
  - id: HP:0002180
    label: neurodegeneration
  - id: MAXO:0001001
    label: gene therapies
  - id: MAXO:0000127
    label: genetic testing
  - id: MONDO:0020696
    label: Vitamin B12 Deficiency
  - id: MAXO:0000760
    label: Vitamin B12 supplementation
  - id: MAXO:0000427
    label: MRI of the brain
  - id: CHEBI:176843
    label: Vitamin B12
  - id: MONDO:0020380
    label: Spinocerebellar Ataxia (SCA)
  - id: HP:0001272
    label: Cerebellar atrophy
  - id: MONDO:0004975
    label: Alzheimer's disease
  - id: MONDO:0017276
    label: frontotemporal dementia
  - id: MONDO:0004976
    label: amyotrophic lateral sclerosis
  - id: MONDO:0007661
    label: Tourette Syndrome
  - id: HP:0002072
    label: Chorea
  - id: MONDO:0005071
    label: Neurological Disorders
  - id: MAXO:0000647
    label: Chemotherapy
  - id: HP:0100543
    label: Cognitive impairment
  - id: HP:0012174
    label: glioblastoma
  - id: MONDO:0005109
    label: HIV
  - id: MONDO:0005559
    label: Neurodegenerative diseases
  - id: CHEBI:16243
    label: quercetin
  - id: CHEBI:3962
    label: curcumin
  - id: CHEBI:27881
    label: resveratrol
  - id: CHEBI:75095
    label: chrysin
  - id: CHEBI:28821
    label: piperine
  - id: CHEBI:17620
    label: ferulic acid
  - id: CHEBI:78330
    label: huperzine A
  - id: CHEBI:16118
    label: berberine
  - id: CHEBI:2979
    label: baicalein
  - id: CHEBI:28230
    label: hesperetin
  - id: CHEBI:26536
    label: retinoic acid
  - id: HP:0002015
    label: Dysphagia
  - id: CHEBI:50202
    label: Naringenin
  - id: CHEBI:16348
    label: 3-nitropropionic acid
  - id: CHEBI:28790
    label: Serotonin
  - id: HP:0000709
    label: psychosis
  - id: HP:0011951
    label: aspiration pneumonia
  - id: HP:0000716
    label: depression
  - id: MAXO:0000065
    label: aerobic exercises
  - id: MAXO:0000610
    label: enzyme-linked immunosorbent assays
  - id: CHEBI:53444
    label: potassium dichromate
  - id: CHEBI:141442
    label: Manganese (Mn)
  - id: HP:0100021
    label: Cerebral palsy
  - id: HP:0001915
    label: Aplastic anemia
  - id: MAXO:0000079
    label: genetic counseling
  - id: HP:0000708
    label: behavioral problems
  - id: HP:0004421
    label: Elevated systolic blood pressure
  - id: MONDO:0005180
    label: Parkinson disease
  - id: MONDO:0005098
    label: stroke
  - id: MONDO:0005301
    label: multiple sclerosis
  - id: HP:0000739
    label: anxiety
  - id: CHEBI:7872
    label: oxytocin
  - id: CHEBI:9937
    label: vasopressin
  - id: HP:0033429
    label: neuroinflammation
  - id: MAXO:0000016
    label: Cell Therapy
  - id: CHEBI:6437
    label: levetiracetam
  - id: MAXO:0000900
    label: Electrocardiograms (ECGs) collection
  - id: HP:0040141
    label: Tardive dyskinesia
  - id: MONDO:0010096
    label: tardive dyskinesia
  - id: HP:0005268
    label: Spontaneous abortion
  - id: CHEBI:16675
    label: quinolinic acid
  - id: MONDO:0001627
    label: Dementias
  - id: HP:0001300
    label: parkinsonism
  - id: CHEBI:76720
    label: antisense oligonucleotide
  - id: CHEBI:192545
    label: LY379268
